Hijacking Human Rights in Latin America
By Gina Maranto, Biopolitical Times guest contributor
| 05. 03. 2011
In 2009, a Buenos Aires civic association awarded a prize named after American civil rights activist Rosa Parks to Argentinian Senator Liliana Negre de Alonso. The prize was given “por la Defensoría de la Vida Humana,” but the recipient’s resumé hardly resembles that of a typical human rights advocate. Negre de Alonso has a history of opposing laws and policies that favor sexual and reproductive choice. In 2006, for instance, she fought against a bill that sought to provide all Argentinians access to free vasectomies or tubal ligations. Among other things, she argued that it would promote HIV transmission by lessening the need for condoms. She has long opposed abortion, and last year, she waged a highly emotional campaign against Argentina’s landmark same-sex marriage law.
Negre de Alonso, a member of the highly conservative Opus Dei movement, which defines itself as the “personal prelature of the Catholic Church”, was exhibit Number One in a recent talk by anthropologist Lynn Morgan at the University of Miami. Morgan, the Mary E. Woolley Professor of Anthropology at...
Related Articles
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...